Home
Product
Protein
Active Protein
Other
Recombinant Human C-C chemokine receptor type 8 (CCR8)-VLPs (Active)

Recombinant Human C-C chemokine receptor type 8 (CCR8)-VLPs (Active)

In Stock

Code: CSB-MP004847HU

Rate （5.0）
Review （1）

Size:

20ug100ug1mg

US$558

Quantity:

Express system: Mammalian cell

Species: Homo sapiens (Human)

Tag Info: C-terminal 10xHis-tagged (This tag can be tested only under denaturing conditions)

Send an Inquiry

Start an on-line Chat

Online ordering is currently available for U.S. customers only. For orders outside the U.S., please kindly submit an inquiry or start a chat with us.

Product Details
Related Products
Customer Reviews and Q&A
Target Background

Product Details

Abbreviation

Recombinant Human CCR8 protein-VLPs (Active)

Purity

Greater than 90% as determined by SEC-HPLC.

Endotoxin

Less than 1.0 EU/ug as determined by LAL method.

Activity

Measured by its binding ability in a functional ELISA. Immobilized human CCR8 (CSB-MP004847HU) at 5 μg/ml can bind Anti-CCR8 recombinant Antibody, the the EC₅₀ is 11.13-17.29 ng/ml.

Target Names

CCR8

Uniprot NO.

P51685

Research Area

cancer

Alternative Names

CCR8; CKRL1; CMKBR8; CMKBRL2; C-C chemokine receptor type 8; C-C CKR-8; CC-CKR-8; CCR-8; CC chemokine receptor CHEMR1; Chemokine receptor-like 1; CKR-L1; GPR-CY6; GPRCY6; TER1; CD antigen CDw198

Species

Homo sapiens (Human)

Source

Mammalian cell

Expression Region

1-355aa

Target Protein Sequence

MDYTLDLSVTTVTDYYYPDIFSSPCDAELIQTNGKLLLAVFYCLLFVFSLLGNSLVILVLVVCKKLRSITDVYLLNLALSDLLFVFSFPFQTYYLLDQWVFGTVMCKVVSGFYYIGFYSSMFFITLMSVDRYLAVVHAVYALKVRTIRMGTTLCLAVWLTAIMATIPLLVFYQVASEDGVLQCYSFYNQQTLKWKIFTNFKMNILGLLIPFTIFMFCYIKILHQLKRCQNHNKTKAIRLVLIVVIASLLFWVPFNVVLFLTSLHSMHILDGCSISQQLTYATHVTEIISFTHCCVNPVIYAFVGEKFKKHLSEIFQKSCSQIFNYLGRQMPRESCEKSSSCQQHSSRSSSVDYIL
Note: The complete sequence may include tag sequence, target protein sequence, linker sequence and extra sequence that is translated with the protein sequence for the purpose(s) of secretion, stability, solubility, etc.
If the exact amino acid sequence of this recombinant protein is critical to your application, please explicitly request the full and complete sequence of this protein before ordering.

Mol. Weight

42.2 kDa

Protein Length

Full Length

Tag Info

C-terminal 10xHis-tagged (This tag can be tested only under denaturing conditions)
The tag type will be determined during production process. If you have specified tag type, please tell us and we will develop the specified tag preferentially.

Buffer

PBS, pH 7.4, 6% trehalose

Storage

Store at -20°C/-81°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.

Lead Time

Basically, we can dispatch the products out in 3-7 working days after receiving your orders. Delivery time may differ from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Note: All of our proteins are default shipped with normal blue ice packs, if you request to ship with dry ice, please communicate with us in advance and extra fees will be charged.

Notes

Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.

Shelf Life

The shelf life is related to many factors, storage state, storage temperature and the stability of the product itself. Generally, the shelf life of lyophilized form is 6 months at -20°C/-80°C from the date of receipt.

Troubleshooting and FAQs

Protein FAQs

Datasheet & COA

Please contact us to get it.

Images

CSB-MP004847HU is detected by Mouse anti-6*His monoclonal antibody.
CSB-MP004847HU is detected by Anti-CCR8 recombinant Antibody
Activity
Measured by its binding ability in a functional ELISA. Immobilized human CCR8 (CSB-MP004847HU) at 5 μg/ml can bind Anti-CCR8 recombinant Antibody, the the EC₅₀ is 11.13-17.29 ng/ml.
The presence of VLP-like structures was confirmed by TEM
Loaded Anti-Human CCR8 Antibody (CSB-RA004847MA3HU) on 96-Flat plate, can bind Human CCR8, with an affinity constant of ＜1 pM as determined in BLI assay (Gator Prime).
The purity of VLPs was greater than 90% as determined by SEC-HPLC

Description

CCR8 has emerged as a compelling immunotherapy target due to its selective expression on tumor-infiltrating regulatory T cells, making it a focus of therapeutic antibody development in immuno-oncology. This recombinant human CCR8 construct spans the full-length sequence (aa 1–355) and is presented on virus-like particles derived from mammalian cells, preserving the multi-pass transmembrane topology and native conformational epitopes that are critical for GPCR targets. Functional ELISA confirms binding to an anti-CCR8 recombinant antibody with an EC50 of 11.13–17.29 ng/ml when immobilized at 5 μg/ml, providing a suitable basis for blocking antibody screening, therapeutic antibody epitope mapping, and ligand-receptor interaction studies via ELISA, SPR, or BLI. Endotoxin levels below 1.0 EU/μg, combined with the VLP format that maintains conformational integrity, support use in drug discovery workflows targeting CCR8-mediated immune suppression in the tumor microenvironment.

Customer Reviews and Q&A

■ Customer Reviews

Average Rating:

5.0 - 1 reviews

Submit a Review here

Applications : Drug related studies

Review: CCR8 is a multi-pass transmembrane protein, and expressing only its extracellular domain can disrupt its conformational epitopes, resulting in the loss of some antigenic epitopes. Your company has developed this full-length protein with good biological activity and immunogenicity. It will be very helpful for our company\'s subsequent development of antibody drugs.

By Anonymous

■ Q&A

I notice you provide CCR8 nanodiscs, could you inform me about the exposure of both the intracellular and extracellular domain? We would like to screen a panel of antibodies with potency for detecting either intracellular or extracellular epitopes of this target.
For a VLP, per definition the intracellular domain is not exposed, as I am aware of, which is not ideal for our purpose.

VLP only exposes the extracellular domain, and the intracellular domain is not exposed in the envelope, which is mainly to screen and recognizes the extracellular epitopes, so VLP may not be suitable for customers' experiments. The customer would like to screen a group of antibodies that can detect the intracellular or extracellular site of the target. We recommend CSB-CF004847HU ，which express full-length protein by a cell-free expression system, but no activity test was performed and it is not guaranteed to identify the endogenous sample. Or it is suggested that the customer select the intracellular or extracellular domain sequence of the target protein for recombinant expression, and screen the antibodies that identify the intracellular or cellular epitopes of the target, but can not guarantee the recognition of endogenous samples.

Target Background

Function(From Uniprot)

Receptor for the chemokine CCL1/SCYA1/I-309. May regulate monocyte chemotaxis and thymic cell line apoptosis. Alternative coreceptor with CD4 for HIV-1 infection.

Gene References into Functions

Authors demonstrate the pivotal role of CCR8(+) Treg cells in restraining immunity and highlight the potential clinical implications of this discovery. PMID:28533380
Role of Conserved Disulfide Bridges and Aromatic Residues in Extracellular Loop 2 of Chemokine Receptor CCR8 for Chemokine and Small Molecule Binding. PMID:27226537
High CCR8 expression is associated with high recurrence in kidney cancer. PMID:26716905
findings suggest that CCR8 expression in ALCL is more closely related to the presence of DUSP22 rearrangements than to cutaneous involvement and that the function of CCR8 may extend beyond its skin-homing properties in this disease PMID:25390351
Epidermal-derived vitamin D3 metabolites and prostaglandins provide an essential cue for the localization of CCR8+ immune surveillance T cells within healthy human skin. PMID:26002980
CCL1-CCR8 interaction may play a critical role in lymphocytic recruitment in IgG4-related sclerosing cholangitis and type 1 autoimmune pancreatitis, leading to duct-centred inflammation and obliterative phlebitis. PMID:23811304
Identification of human CCR8 as a CCL18 receptor. PMID:23999500
CCR8(+) myeloid cell subset is expanded in patients with cancer. PMID:23363815
Data show that CCR8 expression by newly activated naive T cells is regulated by skin-specific factor(s) derived primarily from epidermal keratinocytes. PMID:23043070
C-terminal clipping of chemokine CCL1/I-309 enhances CCR8-mediated intracellular calcium release and anti-apoptotic activity PMID:22479563
The functional data from human macrophages suggest a potential cross talk between the CCR8 and the Toll-like receptor 4 (TLR4) pathways, both of which are present in chronic obstructive pulmonary disease patients. PMID:21976223
There may be a role for CCR8 in the recruitment of T cells to the lung in asthmatics. PMID:20455898
CCR8 mediates rescue from dexamethasone-induced apoptosis via an ERK-dependent pathway PMID:12525579
found in the central nervous system and is associated with phagocytic macrophages PMID:12547701
CCR8 genes and surrounding genomic regions these genes are the result of the duplication of an ancestral gene prior to the divergence of teleost fish. PMID:12551893
Transfected human CCR8-dependent activation of the RAS/MAPK pathway mediates anti-apoptotic activity of I-309/ CCL1 and vMIP-I. PMID:12645948
The induction of CCR8 under conditions associated with vascular smooth muscle cell proliferation and migration raises the possibility that CCR8 may play an important role in vessel wall pathology. PMID:14576057
the axis CCL1-CCR8 links adaptive and innate immune functions that play a role in the initiation and amplification of atopic skin inflammation PMID:15814739
CCR8 ligands are allotropic, binding to distinct sites within CCR8; the human immune system may have evolved to use CCL7 as a selective antagonist of viral chemokine activity at CCR8 but not those of the host ligand PMID:17023422
CCR8 is expressed by a small and heterogeneous population of peripheral blood CD4 memory T cells enriched in T helper type 2 (Th2) effector and T regulatory (Treg) cells. PMID:17082609
CCR8-expressing CD4-positive T lymphocytes are preferentially recruited from the periphery into the lungs of asthmatic individuals, driven by elevated CCL1 levels produced almost exclusively by mast cells and basophils. PMID:17641040
The combination of 17beta-E(2) with the environmental pollutant TCDD is involved in the pathogenesis of endometriosis via up-regulating the chemokine CCR8-I-309. PMID:17693327